Abstract
Myelodysplastic syndrome (MDS) is an adult hematological disease that evolves into acute myeloid leukemia (AML) in about 30% of the cases. The availability of a highly specific probe moved us to perform in patients affected with MDS/AML, associated with normal karyotype, painting and fluorescence in situ hybridization (FISH) analysis aimed to check the inositide-specific phospholipase C (PI-PLC) β1 gene, a player in the control of some checkpoints of the cell cycle. Here we present a preliminary observation in which FISH analysis disclosed in a small group of MDS/AML patients with normal karyotype the monoallelic deletion of the PI-PLCβ1 gene. On the contrary, PI-PLC β4, another gene coding for a signaling molecule, located on 20p12.3 at a distance as far as less than 1Mb from PI-PLCβ1, is unaffected in MDS patients with the deletion of PI-PLC β1 gene, hinting at an interstitial deletion. The MDS patients, bearing the deletion, rapidly evolved to AML. The data suggest the possible involvement of PI-PLCβ1 in the progression of the disease and pave the way for a larger investigation aimed at identifying a possible high-risk group among MDS patients with a normal karyotype.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Silverman LR . Myelodysplastic syndrome. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei E (eds). Cancer Medicine, 5th edn. Hamilton (Canada): BC Decker Inc. Publ., 2000, pp. 123.
Zeidman A, Dayan DB, Mittelman M . Secondary myelodysplastic syndromes and acute leukemias. Haematologia 1995; 27: 23–28.
Mrózek K, Heinonen K, de la Chapelle A, Bloomfield CD . Clinical significance of cytogenetics in acute myeloid leukemia. Semin Oncol 1997; 24: 17–31.
Bloomfield CD, Shuma C, Regal L . Long-term survival of patients with acute myeloid leukemia. A third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997; 80 (Suppl): 2191–2198.
Caligiuri MA, Bloomfield CD . The molecular biology of leukemia. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds). Cancer: Principles & Practice of Oncology, 6th edn. Philadelphia, PA: Lippincott-Raven, 2000, pp. 2389–2404.
Sheikhha MH, Awan A, Tobal K, Liu Yin JA . Prognostic significance of FLT3 ITD and D835 mutations in AML patients. Hematol J 2003; 4: 41–46.
Peruzzi D, Aluigi M, Manzoli L, Billi AM, Di Giorgio FP, Morleo M et al. Molecular characterization of the human PLCβ1 gene. Biochim Biophys Acta 2002; 1584: 46–54.
Martelli AM, Manzoli L, Faenza I, Bortul R, Billi A, Cocco L . Nuclear inositol lipid signaling and its potential involvement in malignant transformation. Biochim Biophys Acta (Rev. Cancer) 2002; 1603: 10–16.
Peruzzi D, Calabrese G, Faenza I, Manzoli L, Matteucci A, Gianfrancesco F et al. Identification and chromosomal localisation by fluorescence in situ hybridisation of human gene of phosphoinositide-specific phospholipase Cβ1. Biochim Biophys Acta 2000; 484: 175–182.
Hu J, Jiang CC, Ng HK, Pang JC, Tong CY, Chen SQ . An allelotype study of primary and corresponding recurrent glioblastoma multiforme. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003; 20: 56–58.
Gordon A, McManus A, Anderson J, Fisher C, Abe S, Nojima T et al. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3–FOXO1A fusion gene in one case. Cancer Genet Cytogenet 2003; 140: 73–77.
Peng Z, Zhou C, Zhang F, Ling Y, Tang H, Bai S et al. Loss of heterozygosity of chromosome 20 in sporadic colorectal cancer. Chin Med J (Engl) 2002; 115: 1529–1532.
Wada N, Duh QY, Miura D, Brunaud L, Wong MG, Clark OH . Chromosomal aberrations by comparative genomic hybridization in hurthle cell thyroid carcinomas are associated with tumor recurrence. J Clin Endocrinol Metab 2002; 87: 4595–4601.
Le Beau MM . Cytogenetics Analysis of Hematological Malignant Diseases. In: Barch MJ (ed). The ACT Cytogenetics Laboratory Manual, Chapter 9, 2nd edn. New York, NY: Raven Press, 1991, pp. 395–449.
Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA et al. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494–497.
Calabrese G, Fantasia D, Spadano A, Morizio E, Di Bartolomeo P, Palka G . Karyotype refinement in five patients with acute myeloid leukemia using spectral karyotyping. Haematologica 2000; 85: 1219–1221.
Calabrese G, Sallese G, Stornaiuolo A, Morizio E, Palka G, De Blasi A . Assignment of the beta-arrestin 1 gene (ARRB1) to human chromosome 11q13. Genomics 1994; 23: 169–171.
Castro PD, Fairman J, Nagarajan L . The unexplored 5q13 locus: a role in hematopoietic malignancies. Leuk Lymphoma 1998; 30: 443–448.
Mori N, Morosetti R, Hoflehner E, Lubbert M, Mizoguchi H, Koeffler HP . Allelic loss in the progression of myelodysplastic syndrome. Cancer Res 2000; 60: 3039–3042.
Martelli AM, Gilmour RS, Bertagnolo V, Neri LM, Manzoli L, Cocco L . Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells. Nature 1992; 358: 242–245.
Cocco L, Martelli AM, Barnabei O, Manzoli FA . Nuclear inositol lipid signaling. Adv Enzyme Regul 2001; 41: 361–384.
Alvarez RA, Ghalayini AJ, Xu P, Hardcastle A, Bhattacharya S, Rao PN et al. cDNA sequence and gene locus of the human retinal phosphoinositide-specific phospholipase-C beta 4 (PLCB4). Genomics 1995; 29: 53–61.
Faenza I, Matteucci A, Manzoli L, Billi AM, Aluigi M, Peruzzi D et al. A role for nuclear phospholipase Cβ1 in cell cycle control. J Biol Chem 2000; 275: 30520–30524.
Faenza I, Bavelloni A, Fiume R, Lattanzi G, Maraldi NM, Gilmour RS et al. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol 2003; 195: 446–452.
Acknowledgements
Acknowledgments for research support: This work was supported by grants from: AIRC, CARISBO Foundation, Italian MIUR Cofin, Italian CNR-MIUR Oncology Project.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lo Vasco, V., Calabrese, G., Manzoli, L. et al. Inositide-specific phospholipase c β1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 18, 1122–1126 (2004). https://doi.org/10.1038/sj.leu.2403368
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403368
Keywords
This article is cited by
-
Phosphoinositide-specific phospholipase C isoforms are conveyed by osteosarcoma-derived extracellular vesicles
Journal of Cell Communication and Signaling (2020)
-
U-73122 reduces the cell growth in cultured MG-63 ostesarcoma cell line involving Phosphoinositide-specific Phospholipases C
SpringerPlus (2016)
-
Ezrin-related Phosphoinositide pathway modifies RhoA and Rac1 in human osteosarcoma cell lines
Journal of Cell Communication and Signaling (2015)
-
Ezrin silencing remodulates the expression of Phosphoinositide‐specific Phospholipase C enzymes in human osteosarcoma cell lines
Journal of Cell Communication and Signaling (2014)
-
Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma
Leukemia (2010)